Antioxidant Effects of Modified Bufei Tang Combined with Methylprednisolone on IPF Rats

YANG Chang-fu; LI Hong; MA Qiu-xia; QING Yong-jun; CHEN Shun-xiang; WU Zhi-yong; LI Jian; ZOU Bo-huang-jin; LIN Chang; DENG Ying

doi:10.13422/j.cnki.syfjx.2016090081

您当前的位置：

首页 >

文章列表页 >

Antioxidant Effects of Modified Bufei Tang Combined with Methylprednisolone on IPF Rats

更新时间：2024-01-04

- Antioxidant Effects of Modified Bufei Tang Combined with Methylprednisolone on IPF Rats
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 22, Issue 9, Pages: 81-85(2016)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2016090081
  CLC： R285.5
- Published：2016
- 稿件说明：
移动端阅览
YANG Chang-fu, LI Hong, MA Qiu-xia, et al. Antioxidant Effects of Modified Bufei Tang Combined with Methylprednisolone on IPF Rats[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(9): 81-85.
DOI：

YANG Chang-fu, LI Hong, MA Qiu-xia, et al. Antioxidant Effects of Modified Bufei Tang Combined with Methylprednisolone on IPF Rats[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(9): 81-85. DOI： 10.13422/j.cnki.syfjx.2016090081.

摘要

目的: 观察加减补肺汤联合甲强龙对博来霉素诱导的特发性肺纤维化(IPF)大鼠抗氧化作用

探讨其作用机制。方法: 60只SD大鼠随机分为正常组

模型组

甲强龙组(10 mg·kg-1·d-1)

加减补肺汤组(100 mg·kg-1·d-1)

联合用药1组

联合用药2组

每组10只。除正常组外其余各组大鼠采用气管内一次性滴注博来霉素复制IPF模型(1 mg/只)

造模24 h后

开始ig或im给药

持续到处死动物的前1 d

模型组ig等体积的生理盐水。计算IPF大鼠肺系数

观察肺组织形态学改变

测定各组大鼠肺组织匀浆中羟脯氨酸(Hyp)

丙二醛(MDA)含量和超氧化物歧化酶(SOD)的活性

取固定部位肺组织分别进行苏木素-伊红(HE)染色。结果: 与正常组比较

模型组大鼠肺泡炎细胞浸润及肺间质纤维化程度明显

肺系数明显升高

肺组织中Hyp

MDA含量明显升高、肺组织中SOD的活性明显降低(P<0.05

P<0.01);与模型组比较

各给药组均可改善IPF大鼠的生存状态

甲强龙组、加减补肺汤组和联合用药1组可明显改善IPF大鼠肺泡炎细胞浸润及肺间质纤维化程度

显著降低肺系数(P<0.01

P<0.05)

降低肺组织中Hyp

MDA含量、升高肺组织中SOD的活性。结论: 联合用药1组对降低IPF大鼠肺组织中肺系数

Hyp和MDA的含量

升高肺组织中SOD活性

优于单独给药

其机制可能是减少脂质过氧化物的释放而达到抗氧化作用。

Abstract

Objective: To observe the antioxidant effects of modified Bufei Tang (MBT) combined with methylprednisolone on bleomycin-induced idiopathic pulmonary fibrosis (IPF) in rats

and investigate the mechanism. Method: Sixty Sprague-Dawley rats were randomly divided into normal group

model group

methylprednisolone group (10 mg·kg-1·d-1)

MBT group (100 mg·kg-1·d-1)

combined treatment group 1

and combined treatment group 2

n=10 in each group. The IPF models were reproduced by intratracheal injection of bleomycin (1 mg for each rat). 24 hours after modeling

the rats were treated with daily intragastric administration or intramuscular injection until one day before sacrificing. The rats in model group were treated with the same volume of normal saline. Lung coefficient was calculated

and lung tissue morphology changes were observed in IPF rats. The hydroxyproline (Hyp)

malondialdehyde (MDA) and superoxide dismutase (SOD) levels in lung homogenates of rats were measured. Hematoxylin-eosin staining was applied for fixed lung tissues. Result: As compared with the normal group

degree of alveolar inflammatory cells infiltration and pulmonary fibrosis was obvious;lung coefficient was increased significantly;Hyp and MDA levels in liver tissues were increased significantly;and SOD activity in liver tissues was decreased significantly in the rats of model group (P<0.05

P<0.01). Various treatment groups could improve the living state of IPF rats;methylprednisolone group

MBT group

and combined treatment group 1 could significantly improve the degree of alveolar inflammatory cells infiltration and pulmonary interstitial fibrosis of IPF rats

significantly reduce lung coefficient (P<0.01

P<0.05)

reduce Hyp and MDA levels in the lung tissues and increase SOD activity in the lung tissues. Conclusion: Combined treatment group 1 has superior effect than single treatment in reducing liver coefficient

Hyp and MDA levels and increasing SOD activity in the lung tissues of IPF rats. The mechanism might be related to decreasing the level of lipid peroxide to achieve antioxidant effects.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Shengxiantang Alleviates Idiopathic Pulmonary Fibrosis in Rats by Regulating Oxidative Stress to Inhibit PANoptosis

Clinical Randomized Controlled Trial of Traditional Chinese Medicine Compound Shenlong Decoction Granules in Treatment of Idiopathic Pulmonary Fibrosis

Exploring Immune Mechanism of Alveolar Epithelial Homeostasis in Idiopathic Pulmonary Fibrosis Based on Principle of "Spleen being in Charge of Defensive Function"

Rho/ROCK：key Mediator of Pulmonary Fibrosis and New Target of TCM for IPF Prevention and Treatment

Regulatory Effect of Xiaoyaosan Combined with Pirfenidone on Idiopathic Pulmonary Fibrosis and Depression in Rats Based on p38 MAPK/NF-κB Inflammatory Pathway

Related Author

LIANG Yulei

YAN Yanan

LI Wei

LIU Na

FANG Chaoyi

WANG Jiepeng

SI Qi

ZANG Ningzi

Related Institution

Hebei Key Laboratory of Integrated Chinese and Western Medicine for Lung Disease Research

Hebei University of Chinese Medicine

Liaoning University of Traditional Chinese Medicine（TCM）

Affiliated Hospital of Liaoning University of TCM

Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan & Ministry of Education of PR China，Henan Key Laboratory of Chinese Medicine for Respiratory Disease， Academy of Chinese Medical Sciences，Henan University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰